People 65 years and older and those with weakened immunity are eligible for additional COVID-19 boosters; some health insurers are beginning to cover telehealth abortion; apps are enticing nurses to take gig work beyond employees.
The FDA amended emergency use authorization terms for the Pfizer and Moderna bivalent COVID-19 vaccines Tuesday, permitting people 65 years and older and certain individuals with weakened immunity to receive additional doses prior to this fall’s vaccination campaigns, reported CNN. The bivalent vaccines have been available in the United States since September under emergency use authorizations that restrict how the vaccines are dispensed. The FDA also issued updates to simplify the recommended vaccine doses for unvaccinated people.
Telehealth is becoming a more accepted and established method of care, including care for abortion, simultaneous with the legal battles around mail-order abortion pills, according to The New York Times. Some new virtual clinics have started contracting with major health insurers for coverage. Insurance coverage for abortion varies, and plans that do cover abortion coverage usually don’t include new telehealth providers such as the virtual clinics in their networks. The inclusion of some telehealth abortion providers by insurers is a recent sign that virtual abortion clinics are starting to be considered a safe and in-demand option, the article notes.
Some of the largest hospital systems in the United States are using apps to entice scarce nurses to book shift work, reported The Wall Street Journal. One app helps hospitals adjust pay to match supply, lowering or raising rates depending on the need of the hospital and shift popularity, while another allows workers to bid for shifts. Proponents say the adoption of gig work puts hospitals in more direct competition with temporary staffing agencies and helps them extend their labor pool outside of their employees to other nurses who value flexible schedules.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More